reference/18656047

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18656047

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	815
issn	0959-4973
issueIdentifier	8
pageRange	811-815
publicationName	Anti-Cancer Drugs
startingPage	811
bibliographicCitation	Riccardi A, Meco D, Ubezio P, Mazzarella G, Marabese M, Faircloth GT, Jimeno J, D'Incalci M, Riccardi R. Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft. Anticancer Drugs. 2005 Sep;16(8):811–5. doi: 10.1097/01.cad.0000172837.67766.6a. PMID: 16096428.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e71f7db039824d98292feaf9a2e25ee6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9379-0301 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6263c4abf49958db1faf052ec97816d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65ce8f57c27a95d96782b73cbd174a87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e097ef7219f3cfacea97e0a9dc88d8c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_671d2210c9e65601df8ad23a0341ac99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bd382188e8d5f3eb3da4e978cf8e96a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb17a36273f0327f08bb0011f90d6dff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d02e637920bf1134dd131d726b6b2e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0412-9891 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebc9b617c160edfa622bfa2f4037ce21
date	200509
identifier	https://doi.org/10.1097/01.cad.0000172837.67766.6a https://pubmed.ncbi.nlm.nih.gov/16096428
isPartOf	https://portal.issn.org/resource/ISSN/0959-4973 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1267
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft
discusses	http://id.nlm.nih.gov/mesh/M0003242 http://id.nlm.nih.gov/mesh/M0453081 http://id.nlm.nih.gov/mesh/M0444141 http://id.nlm.nih.gov/mesh/M0006500 http://id.nlm.nih.gov/mesh/M0147530 http://id.nlm.nih.gov/mesh/M0381011 http://id.nlm.nih.gov/mesh/M0011785
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D012208Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007546Q000008 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D066298 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004149Q000008 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000077606 http://id.nlm.nih.gov/mesh/D004264Q000378 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D002166Q000031 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D002166Q000008 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D044005 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D000077146
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104842 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108150 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60837 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9105 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_25a8407af12d92ed31eea1508a1b4f98 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74990

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129430288 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520161 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248774860

Total number of triples: 64.